SCHEMBL30658056

SCHEMBL30658056

CC(C)(C)OC(=O)N1CC(c2cc3nnc(-c4ccccc4O)cc3[nH]2)C1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 3/20 0.52
▸ SMARCA4 P51532 3/20 0.52
▸ PBRM1 Q86U86 3/20 0.52
▸ BACE1 P56817 6/20 0.39
▸ BACE2 Q9Y5Z0 2/20 0.39
▸ CCNK O75909 1/20 0.38
▸ CDK12 Q9NYV4 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PIM2 Q9P1W9 1/20 0.38
▸ HPGDS O60760 2/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26654036 1.00 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL30658017 0.90 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL26654083 0.90 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL26654056 0.86 SMARCA2 (0.38) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL30658000 0.86 SMARCA2 (0.38) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL24461312 0.84 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL29619413 0.84 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL30658057 0.80 KDM4E (0.40) BACE1BACE2CCNKCDK12KDM4E
SCHEMBL26653835 0.80 KDM4E (0.40) BACE1BACE2CCNKCDK12KDM4E
SCHEMBL26654087 0.79 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1KDM4EIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522279-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220134-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback